why Insmed Inc [INSM] is a Good Choice for Investors After New Price Target of $113.71

MU Stock

Insmed Inc [NASDAQ: INSM] traded at a high on 2025-07-16, posting a 1.67 gain after which it closed the day’ session at $104.59.

The results of the trading session contributed to over 3691223 shares changing hands. Over the past one week, the price volatility of Insmed Inc stands at 3.50% while the volatility over the past one month is 3.01%.

The market cap for INSM stock reached $19.87 billion, with 189.95 million shares outstanding and 185.73 million shares in the current float. Compared to the average trading volume of 3.77M shares, INSM reached a trading volume of 3691223 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about Insmed Inc [INSM]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for INSM shares is $113.71 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on INSM stock is a recommendation set at 1.05. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Jefferies have made an estimate for Insmed Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on May 13, 2025. While these analysts kept the previous recommendation, RBC Capital Mkts raised their target price to Outperform. The new note on the price target was released on February 25, 2025, representing the official price target for Insmed Inc stock. Previously, the target price had yet another raise to $48, while Truist analysts kept a Buy rating on INSM stock.

The Price to Book ratio for the last quarter was 191.86, with the Price to Cash per share for the same quarter was set at 6.31.

How has INSM stock performed recently?

Insmed Inc [INSM] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 8.42. With this latest performance, INSM shares gained by 5.94% in over the last four-week period, additionally plugging by 51.73% over the last 6 months – not to mention a rise of 51.49% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for INSM stock in for the last two-week period is set at 70.21, with the RSI for the last a single of trading hit 3.18, and the three-weeks RSI is set at 3.30 for Insmed Inc [INSM]. The present Moving Average for the last 50 days of trading for this stock 84.25, while it was recorded at 100.84 for the last single week of trading, and 76.23 for the last 200 days.

Insmed Inc [INSM]: Deeper insight into the fundamentals

Operating Margin for any stock indicates how profitable investing would be, and Insmed Inc [INSM] shares currently have an operating margin of -225.44% and a Gross Margin at 75.17%. Insmed Inc’s Net Margin is presently recorded at -265.93%.

Return on Equity for this stock declined to -68.42%, with Return on Assets sitting at -68.42%. When it comes to the capital structure of this company, Insmed Inc [INSM] has a Total Debt to Total Equity ratio set at 13.21.

Reflecting on the efficiency of the workforce at the company, Insmed Inc [INSM] managed to generate an average of -$797214.79 per employee.Insmed Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.44 and a Current Ratio set at 5.86.

Earnings analysis for Insmed Inc [INSM]

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for INSM. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Insmed Inc go to 48.30%.

Insider trade positions for Insmed Inc [INSM]

There are presently around $111.04%, or 111.87% of INSM stock, in the hands of institutional investors. The top three institutional holders of INSM stocks are: VANGUARD GROUP INC with ownership of 16.01 million shares, which is approximately 10.3509%. BLACKROCK INC., holding 14.26 million shares of the stock with an approximate value of $$955.72 million in INSM stocks shares; and BLACKROCK INC., currently with $$814.95 million in INSM stock with ownership which is approximately 7.8625%.

The DBT News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.